$4.65 2.7%
ELTX Stock Price vs. AI Score
Data gathered: October 14

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Elicio Therapeutics

None


Elicio Therapeutics
Price $4.65
Target Price Sign up
Volume 5,600
Market Cap $52M
Year Range $3.37 - $10.4
Dividend Yield 0%
PE Ratio 5.2
Analyst Rating 100% buy
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q2 '2427,0002.7M-2.8M-7.2M-11M-0.640
Q1 '24120,0002.7M-2.6M-12M-10M-1.150
Q4 '23250,0003.2M-3M-8.9M-9M-1.750
Q3 '2303.5M-3.6M-11M-11M-1.270
Q2 '23600,0002.8M-3M-7.6M-7.8M-2.438

Insider Transactions View All

GKCC, LLC filed to buy 3,442,341 shares at $5.8.
August 14 '24
Venkatesan Jay filed to buy 50,000 shares at $5.
July 2 '24
GKCC, LLC filed to buy 1,600,000 shares at $5.
July 2 '24
GKCC, LLC filed to buy 1,032,702 shares at $5.8.
March 20 '24
GKCC, LLC filed to buy 1,915,639 shares at $5.8.
December 26 '23

What is the Market Cap of Elicio Therapeutics?

The Market Cap of Elicio Therapeutics is $52M.

What is Elicio Therapeutics' PE Ratio?

As of today, Elicio Therapeutics' PE (Price to Earnings) ratio is 5.2.

What is the current stock price of Elicio Therapeutics?

Currently, the price of one share of Elicio Therapeutics stock is $4.65.

How can I analyze the ELTX stock price chart for investment decisions?

The ELTX stock price chart above provides a comprehensive visual representation of Elicio Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Elicio Therapeutics shares. Our platform offers an up-to-date ELTX stock price chart, along with technical data analysis and alternative data insights.

Does ELTX offer dividends to its shareholders?

As of our latest update, Elicio Therapeutics (ELTX) does not offer dividends to its shareholders. Investors interested in Elicio Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Elicio Therapeutics?

Some of the similar stocks of Elicio Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.